Episurf Medical
First Episealer® Talus surgery in India scheduled
Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery in India with the ankle implant Episealer® Talus has been scheduled. Since previously, the Episealer® Knee technology is available in India.
"It is fantastic news to get our first Episealer® Talus approval in India. We have some fantastic support from colleagues in India and initial customer feedback has been positive, and we expect to gain momentum here in the coming months," comments Stephen Caswell, Head of Sales OUS, Episurf Medical.
| Datum | 2023-02-20, kl 16:15 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!